Clinical Trial

Cardiometabolic Disease Risk Factors in Cameroon

Study acronym: URBACAM-D
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
Cardiometabolic diseases (CMDs) are a major public health concern in sub-Saharan Africa, including Cameroon. Studies have shown a significant increase in the prevalence of hypertension, diabetes, and obesity in recent years. However, access to timely diagnosis and treatment remains limited, particularly in rural areas. Community-based screening programs have been shown to be effective in identifying individuals with undiagnosed CMD risk factors and promoting early intervention. By leveraging the strengths of community-based approaches, the URBACAM-D study aims to address the growing burden of CMDs in urban Cameroon.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-25; most recent amendment 2025-11-25.
Status change: Not Yet Recruiting → Enrolling by Invitation 2025-11-25
Trial Details
NCT Number NCT06957548
Lead Sponsor Johns Hopkins University
Conditions Cardiac Disease, Metabolic Disease
Enrollment 200 participants
Start Date 2025-07-09
Primary Completion 2025-10-12 (estimated)
Study Completion 2027-02-12 (estimated)
Updated on ClinicalTrials.gov 2025-11-26